Upregulation of interferon-induced genes in infants with virus-associated acute bronchiolitis

Experimental Biology and Medicine

Volumn 232, Issue 10, 2007, Pages 1355-1359

  Scagnolari, Carolina ^a   Midulla, Fabio ^a   Trombetti, Simona ^a   Pierangeli, Alessandra ^a   Tromba, Valeria ^a   Grossi, Rosanna ^a   Di Marco, Paola ^a   Dianzani, Caterina ^b   Girardi, Enrico ^c   Antonelli, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

2 5 OAS; Bronchiolitis; Interferon; P56; PKR; Rhinovirus; RSV

Indexed keywords

INTERFERON;

ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; MALE; PHARYNX DISEASE; PROTEIN EXPRESSION; UPREGULATION;

BRONCHIOLITIS; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFANT; INTERFERONS; OXYGEN CONSUMPTION; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUSES; RHINOVIRUS;

RHINOVIRUS; RICE STRIPE VIRUS;

EID: 35548934742     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0705-BC-124     Document Type: Article

References (18)

1. Wark PA, Gibson PG. Asthma exacerbations 3: pathogenesis. Thorax 61:909-915, 2006.
2. Johnson TR, Mertz SE, Gitiban N, Hammond S, Legallo R, Durbin RK, Durbin JE. Role for innate IFNs in determining respiratory syncytial virus immunopathology. J Immunol 174:7234-7241, 2005.
3. Isaacs D. Production of interferon in respiratory syncytial virus bronchiolitis. Arch Dis Child 64:92-95, 1989.
4. Fjaerli HO, Bukholm G, Krog A, Skjaeret C, Holden M, Nakstad B. Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis. BMC Infect Dis 6:175, 2006.
5. Wainwright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D, Moloney S, Kimberley A, Woolfield N, Cadzow S, Fiumara F, Wilson P, Mego S, VendeVelde D, Sanders S, O'Rourke P, and Francis P. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute Bronchiolitis. N Engl J Med 349:27-35, 2003.
6. Pierangeli A, Gentile M, Di Marco P, Pagnotti P, Scagnolari C, Trombetti S, Lo Russo L, Tromba V, Moretti C, Midulla F, Antonelli G. Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy. J Med Virol 79:463-468, 2007.
7. Scagnolari C, Trombetti S, Alberelli A, Cicetti S, Bellarosa D, Longo R, Spano A, Riva E, Clementi M, Antonelli G. The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mRNAs for interferon-induced proteins. Intervirology 50:156-160, 2007.
8. Panuska JR, Cirino NM, Midulla F, Despot JE, McFadden ER Jr, Huang YT. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J Clin Invest 86:113-119, 1990.
9. Hewson CA, Jardine A, Edwards MR, Laza-Stanca V, Johnston SL. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol 79:12273-12279, 2005.
10. Groskreutz DJ, Monick MM, Powers LS, Yarovinsky TO, Look DC, Hunninghake GW. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol 176:1733-1740, 2006.
11. Ichikawa T, Nakao K, Nakata K, Yamashita M, Hamasaki K, Shigeno M, Abiru S, Ishikawa H, Ishii N, Eguchi K. Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells. Biochem Biophys Res Commun 294:414-422, 2002.
12. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sanchez PJ, Ramilo O. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 18:115-122, 1999.
13. Midulla F, Tromba V, Lo Russo L, Mileto F, Sabatino G, Sgarrella M, Panuska JR, Manganozzi L, Korn D, Moretti C. Cytokines in the nasal washes of children with respiratory syncytial virus bronchiolitis. Int J Immunopathol Pharmacol 19:231-235, 2006.
14. Lo MS, Brazas RM, Holtzman MJ. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and type I interferon responsiveness. J Virol 79:9315-9319, 2005.
15. Peng T, Kotla S, Bumgarner RE, Gustin KE. Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3. J Virol 80:5021-5031, 2006.
16. Davies DE, Kotenko SV, Papi A, Johnston SL. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12:1023-1026, 2006.
17. Schmidt AC, Johnson TR, Openshaw PJ, Braciale TJ, Falsey AR, Anderson LJ, Wertz GW, Groothuis JR, Prince GA, Melero JA, Graham BS. Respiratory syncytial virus and other pneumoviruses: a review of the international symposium-RSV 2003. Virus Res 106:1-13, 2004.
18. Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG, Piedra PA. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis 195:1532-1540, 2007.